Advertisement

Topics

FDA approves test for detection of certain leukemias and lymphomas

05:35 EDT 3 Jul 2017 | Medical Business Review

The US Food and Drug Administration has allowed marketing of ClearLLab Reagents (T1, T2, B1, B2, M), the first agency authorized test for use with flow cytometry to aid in the detection of several leukemias and lymphomas, including chronic leukemia, acute leukemia, non-Hodgkin lymphoma, myeloma, myelodysplastic syndrome (MDS) and myeloproliferative neoplasms (MPN).

Original Article: FDA approves test for detection of certain leukemias and lymphomas

NEXT ARTICLE

More From BioPortfolio on "FDA approves test for detection of certain leukemias and lymphomas"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Leukemia
Leukemia is a type of cancer of the blood or bone marrow characterized by an abnormal increase of immature white blood cells called "blasts". Leukemia is a broad term covering a spectrum of diseases. In turn, it is part of the even broader grou...